The enforced expression of c-Myc in pig fibroblasts triggers mesenchymal-epithelial transition (MET) via F-actin reorganization and RhoA/Rock pathway inactivation

Cell Cycle

Volumn 12, Issue 7, 2013, Pages 1119-1127

  Shi, Jun Wen ^a,b   Liu, Wei ^a   Zhang, Ting Ting ^a   Wang, Sheng Chun ^a   Lin, Xiao Lin ^a   Li, Jing ^a   Jia, Jun Shuang ^a   Sheng, Hong Fen ^a   Yao, Zhi Fang ^a   Zhao, Wen Tao ^a   Zhao, Zun Lan ^a   Xie, Rao Ying ^a   Yang, Sheng ^a   Gao, Fei ^a   Fan, Quan Rong ^a   Zhang, Meng Ya ^a   Yue, Min ^a   Yuan, Jin ^a   Gu, Wei Wang ^a   Yao, Kai Tai ^a   Xiao, Dong ^a   more..

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b THE FIRST PEOPLE S HOSPITAL OF CHENZHOU   (China)

Author keywords

C Myc; Cytoskeleton reorganization; Dermal fibroblasts; Embryonic fibroblasts; Mesenchymal stem cells; Mesenchymal epithelial transition (MET); RhoA Rock pathway; Tibetan miniature pigs

Indexed keywords

ALPHA CATENIN; CYTOKERATIN; F ACTIN; FIBRONECTIN; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE 14; OCCLUDIN; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL MOTILITY; DEPOLYMERIZATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROBLAST; IMMUNOFLUORESCENCE; MESENCHYMAL STEM CELL; NONHUMAN; ONCOGENE C MYC; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRESS FIBER; SWINE; WESTERN BLOTTING;

EID: 84875882922     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.24164     Document Type: Article

References (38)

1. Dang CV. MYC on the path to cancer. Cell 2012; 149:22-35; PMID:22464321; http://dx.doi. org/10.1016/j.cell.2012.03.003
2. Gustafson WC, Weiss WA. Myc proteins as therapeutic targets. Oncogene 2010; 29:1249-59; PMID:20101214; http://dx.doi.org/10.1038/onc.2009.512
3. Hynes NE, Stoelzle T. Key signalling nodes in mammary gland development and cancer: Myc. Breast Cancer Res 2009; 11:210; PMID:19849814; http://dx.doi.org/10.1186/bcr2406
4. Larsson LG, Henriksson MA. The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy. Exp Cell Res 2010; 316:1429-37; PMID:20382143; http://dx.doi. org/10.1016/j.yexcr.2010.03.025
5. Laurenti E, Wilson A, Trumpp A. Myc's other life: stem cells and beyond. Curr Opin Cell Biol 2009; 21:844- 54; PMID:19836223; http://dx.doi.org/10.1016/ j. ceb.2009.09.006
6. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008; 8:976-90; PMID:19029958; http://dx.doi.org/10.1038/nrc2231
7. Smith K, Dalton S. Myc transcription factors: key regulators behind establishment and maintenance of pluripotency. Regen Med 2010; 5:947- 59; PMID:21082893; http://dx.doi.org/10.2217/rme.10.79
8. Soucek L, Evan GI. The ups and downs of Myc biology. Curr Opin Genet Dev 2010; 20:91-5; PMID:19962879; http://dx.doi.org/10.1016/j. gde.2009.11.001
9. Smith KN, Lim JM, Wells L, Dalton S. Myc orchestrates a regulatory network required for the establishment and maintenance of pluripotency. Cell Cycle 2011; 10:592-7; PMID:21293186; http://dx.doi. org/10.4161/cc.10.4.14792
10. Cowling VH, Cole MD. E-cadherin repression contributes to c-Myc-induced epithelial cell transformation. Oncogene 2007; 26:3582-6; PMID:17146437; http://dx.doi.org/10.1038/sj.onc.1210132
11. Land H, Parada LF, Weinberg RA. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 1983; 304:596-602; PMID:6308472; http://dx.doi.org/10.1038/304596a0
12. Liu M, Casimiro MC, Wang C, Shirley LA, Jiao X, Katiyar S, et al. p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc Natl Acad Sci USA 2009; 106:19035- 9; PMID:19858489; http://dx.doi.org/10.1073/pnas. 0910009106
13. Trimboli AJ, Fukino K, de Bruin A, Wei G, Shen L, Tanner SM, et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 2008; 68:937-45; PMID:18245497; http://dx.doi. org/10.1158/0008-5472.CAN-07- 2148
14. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985; 318:533-8; PMID:3906410; http://dx.doi.org/10.1038/318533a0
15. Chesi M, Robbiani DF, Sebag M, Chng WJ, Affer M, Tiedemann R, et al. AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies. Cancer Cell 2008; 13:167-80; PMID:18242516; http://dx.doi.org/10.1016/j.ccr.2008.01.007
16. Leder A, Pattengale PK, Kuo A, Stewart TA, Leder P. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 1986; 45:485-95; PMID:3011271; http://dx.doi.org/10.1016/0092- 8674(86)90280-1
17. Cho KB, Cho MK, Lee WY, Kang KW. Overexpression of c-myc induces epithelial mesenchymal transition in mammary epithelial cells. Cancer Lett 2010; 293:230- 9; PMID:20144848; http://dx.doi.org/10.1016/j.canlet. 2010.01.013
18. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119:1420- 8; PMID:19487818; http://dx.doi.org/10.1172/ JCI39104
19. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7:131-42; PMID:16493418; http://dx.doi. org/10.1038/nrm1835
20. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28:15-33; PMID:19169796; http://dx.doi. org/10.1007/s10555-008-9169-0
21. Pinho AV, Rooman I, Real FX. p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells. Cell Cycle 2011; 10:1312-21; PMID:21490434; http://dx.doi.org/10.4161/cc. 10.8.15363
22. Siemens H, Jackstadt R, Hünten S, Kaller M, Menssen A, Götz U, et al. miR-34 and SNAIL form a doublenegative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 2011; 10:4256- 71; PMID:22134354; http://dx.doi.org/10.4161/cc.10.24.18552
23. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010; 12:247-56; PMID:20173740
24. Sakuma K, Aoki M, Kannagi R. Transcription factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial-mesenchymal transition. Proc Natl Acad Sci USA 2012; 109:7776-81; PMID:22547830; http://dx.doi.org/10.1073/pnas.1111135109
25. Zhu W, Cai MY, Tong ZT, Dong SS, Mai SJ, Liao YJ, et al. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition. Gut 2012; 61:562-75; PMID:21813470; http://dx.doi.org/10.1136/gutjnl-2011-300207
26. Amatangelo MD, Goodyear S, Varma D, Stearns ME. c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-βeta induced epithelial-mesenchymal transition and invasion in prostate cancer. Carcinogenesis 2012; 33:1965-75; PMID:22791812; http://dx.doi.org/10.1093/ carcin/bgs227
27. Gasparotto D, Polesel J, Marzotto A, Colladel R, Piccinin S, Modena P, et al. Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas. Oncotarget 2011; 2:1165-75; PMID:22201613
28. Velpula KK, Dasari VR, Tsung AJ, Dinh DH, Rao JS. Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1. Oncotarget 2011; 2:1028-42; PMID:22184289
29. Li R, Liang J, Ni S, Zhou T, Qing X, Li H, et al. A mesenchymal-to- epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010; 7:51-63; PMID:20621050; http://dx.doi.org/10.1016/j. stem.2010.04.014
30. Esteban MA, Xu J, Yang J, Peng M, Qin D, Li W, et al. Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J Biol Chem 2009; 284:17634- 40; PMID:19376775; http://dx.doi.org/10.1074/jbc. M109.008938
31. Jordan NV, Johnson GL, Abell AN. Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle 2011; 10:2865-73; PMID:21862874; http://dx.doi. org/10.4161/cc.10.17.17188
32. Oliveras-Ferraros C, Corominas-Faja B, Cufí S, Vazquez-Martin A, Martin-Castillo B, Iglesias JM, et al. Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin). Cell Cycle 2012; 11:4020-32; PMID:22992620; http://dx.doi.org/10.4161/cc.22225
33. Rubio D, Garcia S, De la Cueva T, Paz MF, Lloyd AC, Bernad A, et al. Human mesenchymal stem cell transformation is associated with a mesenchymal-epithelial transition. Exp Cell Res 2008; 314:691- 8; PMID:18201695; http://dx.doi.org/10.1016/j. yexcr.2007.11.017
34. Deng W, Yang D, Zhao B, Ouyang Z, Song J, Fan N, et al. Use of the 2A peptide for generation of multi-transgenic pigs through a single round of nuclear transfer. PLoS ONE 2011; 6:e19986; PMID:21603633; http://dx.doi.org/10. 1371/journal.pone.0019986
35. Lai L, Kolber-Simonds D, Park KW, Cheong HT, Greenstein JL, Im GS, et al. Production of alpha- 1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295:1089-92; PMID:11778012; http://dx.doi.org/ 10.1126/science. 1068228
36. Liao J, Wu Z, Wang Y, Cheng L, Cui C, Gao Y, et al. Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. Cell Res 2008; 18:600-3; PMID:18414447; http://dx.doi. org/10.1038/cr.2008.51
37. Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, et al. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 2012; 61:278- 89; PMID:21672940; http://dx.doi.org/10.1136/gut.2011.239145
38. Shan SW, Lee DY, Deng Z, Shatseva T, Jeyapalan Z, Du WW, et al. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol 2009; 11:1031-8; PMID:19633662; http://dx.doi.org/10.1038/ncb1917